<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02914730</url>
  </required_header>
  <id_info>
    <org_study_id>CHS #2015-47</org_study_id>
    <nct_id>NCT02914730</nct_id>
  </id_info>
  <brief_title>Insulin Dosing Practices in Persons With Diabetes on Multiple Daily Injections</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Joslin Diabetes Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Joslin Diabetes Center</source>
  <brief_summary>
    <textblock>
      In this cross-sectional study the investigators will examine two populations: young adults
      with (ages 18-35) and older adults (ages 65 and over) with diabetes who are on &gt; 2 insulin
      injections per day. The sample size for this observational study will be up to 125 patients.
      The investigators will issue a Common Sensing GoCap bluetooth-enabled pen cap that fits on
      the end of Solostar Lantus and Apidra insulin pens; this pen cap registers the position of
      the insulin pen plunger and automatically sends confirmation of dose delivery to a smartphone
      app.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2016</start_date>
  <completion_date type="Actual">July 2018</completion_date>
  <primary_completion_date type="Actual">July 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Missed Insulin Doses</measure>
    <time_frame>4 week use of blue tooth pen cap</time_frame>
  </primary_outcome>
  <enrollment type="Actual">75</enrollment>
  <condition>Diabetes</condition>
  <condition>Medication Adherence</condition>
  <condition>Technology</condition>
  <condition>Insulin</condition>
  <eligibility>
    <study_pop>
      <textblock>
        In this cross-sectional study the investigators will examine two populations: young adults
        with (ages 18-35) and older adults (ages 65 and over) with diabetes who are on &gt; 2 insulin
        injections per day. The sample size for this observational study will be up to 125
        patients.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Type 1 diabetes or insulin-requiring Type 2 diabetes

          -  &gt; 2 insulin injections

          -  Age 18-35 or older than 65 years

          -  Use of glargine insulin as basal insulin

          -  Stable insulin doses for past 3 months

        Exclusion Criteria:

          -  Previous tape/adhesive allergies with CGM sensors

          -  Visual or cognitive impairment with inability to self-administer insulin
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Joslin DIabetes Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02215</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2018</verification_date>
  <study_first_submitted>September 22, 2016</study_first_submitted>
  <study_first_submitted_qc>September 22, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 26, 2016</study_first_posted>
  <last_update_submitted>August 10, 2018</last_update_submitted>
  <last_update_submitted_qc>August 10, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">August 14, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Joslin Diabetes Center</investigator_affiliation>
    <investigator_full_name>Medha Munshi</investigator_full_name>
    <investigator_title>Director of Joslin Geriatric Diabetes Programs Beth Israel Deaconess Medical Center Associate Professor of Medicine, Harvard Medical School</investigator_title>
  </responsible_party>
  <keyword>diabetes</keyword>
  <keyword>insulin</keyword>
  <keyword>medication adherence</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

